OBJECTIVE	The goal of this study was to test the hypothesis that exenatide QW is noninferior to insulin glargine , as measured by change in glycosylated hemoglobin ( HbA ( 1c ) ) from baseline to end point ( week 26 [ primary end point ] ) in Japanese patients with type 2 diabetes who have inadequate glycemic control with oral antidiabetes drugs .\